Macular degeneration, often referred to as age-related macular degeneration (AMD), the leading cause of blindness worldwide. It primarily affects the retina, the light- sensitive layer at the back of the eye, with impact on the macula— responsible for sharp, detailed central vision needed for activities like reading and driving.
AMD presents in two forms: dry and wet. Importantly, both types affect central vision
but rarely result in complete blindness.
Dry Macular Degeneration
This form is marked by gradual retinal deterioration alongside the build-up of yellowish deposits called drusen within the macula. As drusen accumulate, the macular tissue thins, leading to visual distortion that often first appears as wavelike patterns. The severity and location of retinal thinning determine the extent of central vision loss.
Wet Macular Degeneration
The exudative, or wet form, is less common, but far more severe. Here, abnormal blood vessels grow beneath the retina and macula in a process known as neovascularization. These vessels may bleed and leak, causing the macula to lift or bulge and resulting in rapid, sometimes profound, loss of central vision.
Low Vision Solutions
Low vision devices offer significant benefits for patients with AMD. These tools can help individuals maximize their remaining sight, retain independence, stay active, and enjoy a better quality of life.
Early intervention with low vision aids is strongly associated with improved long- term outcomes. Patients who begin using vision aids sooner adapt more effectively, while those who delay often face greater challenges once vision loss has progressed.